Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
This study has been completed.
Study NCT00004938   Information provided by Office of Rare Diseases (ORD)
First Received: February 24, 2000   Last Updated: June 8, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sporotrichosis
More general conditions related to this trial
Dermatomycoses
Infection
Mycoses
Skin Diseases
Skin Diseases, Infectious
Interventions listed in this trial
fluconazole
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
University of Alabama at Birmingham


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services